AI-based risk model for breast cancer screening

Researchers assess the performance of an artificial intelligence-based risk model for breast cancer screening in Europe.

Nura Bio secures funding to advance neuroprotective therapies

The company’s lead asset demonstrated neuroprotection in preclinical models of nerve injury and disease. Credit: Jo Panuwat D/Shutterstock. Nura Bio has secured an additional $68m

September 18, 2024

Awakn Selects Eurofins Discovery for Pharmacology Testing in New Chemical Entity (NCE) Pre-Clinical Program | Psychedelic Invest

Toronto, Ontario–(Newsfile Corp. – October 4, 2024) – Awakn Life Sciences Corp. (CSE: AWKN) (OTCQB: AWKNF) (FSE: 954) (“Awakn” or the “Company”), a clinical-stage biotechnology

October 4, 2024

Bentley InnoMed winner of the “EY Entrepreneur of the Year Award 2023” Germany – Biotech Investments

EQS-News: Bentley Endovascular Group AB / Key word(s): Miscellaneous Bentley InnoMed winner of the “EY Entrepreneur of the Year Award 2023” Germany 13.11.2023 / 19:15

November 14, 2023

Supercharge Your Portfolio with Future Health Stocks!

Join us for Profitable Insights & Expert Tips!

With expert analysis, comprehensive market coverage, and actionable insights, our newsletter equips you with the knowledge & tools necessary to make informed decisions & maximize your potential returns in the dynamic world of future health stocks.